eXoZymes, Inc.
EXOZ•NASDAQ•Healthcare•Biotechnology

About eXoZymes

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOMichael Heltzen
Founded2014
Employees31
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.exozymes.com
Phone626 415 1488
Address
750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States

Corporate Identifiers

CIK0002010788
CUSIP461874109
ISINUS4618741098
EIN83-4550057
SIC2836

Leadership Team & Key Executives

Michael Heltzen
President and Chief Executive Officer
Dr. Tyler Korman Ph.D.
Co-Founder and Vice President of Research
Dr. Paul Opgenorth Ph.D.
Co-Founder and Vice President of Development
Fouad Nawaz
Vice President of Finance
James U. Bowie Ph.D.
Founder and Independent Director
Lasse H. Gorlitz
Vice President of Communications
Michael Burns
Executive Vice President of Energy Transition
Dr. Zachary Karl Ph.D.
Vice President and Head of Business Development
Damien A. Perriman
Chief Commercial Officer